NVO - NOVO NORDISK A S

QQQ $ 481.74 $ 2.81 (0.59 %)

DIA $ 391.56 $ 0.33 (0.08 %)

SPY $ 545.33 $ 1.12 (0.21 %)

TLT $ 90.13 $ -1.58 (-1.73 %)

GLD $ 215.59 $ 0.56 (0.26 %)

Previous Close

$ 145.42

Open

$ 143.82

Bid

$ 0.00 x 0

Ask

$ 145.45 x 100

Day's Range

$ 143.81 - $ 145.98

52 Week Range

$ 74.66 - $ 148.15

Volume

3,241,244

Average Volume

Market Cap

655,844

Beta (5Y Monthly)

$ 0.64

PE Ratio (TTM)

$ 0.00

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Beyond The Numbers: 8 Analysts Discuss Nov...
07/01/2024 16:01:21

Cantor Fitzgerald Reiterates Overweight on...
07/01/2024 15:17:46

Cantor Fitzgerald analyst Louise Chen reiterates Novo Nordisk (NYSE:NVO) with a Overweight and maintains $160 price target.

novo-nordisk-options-trading-a-deep-dive-into-market-sentiment

Novo Nordisk Options Trading: A Deep Dive ...
06/28/2024 19:31:31

novo-nordisk-buys-2seventys-hemophilia-a-program-divestiture-supports-exclusive-focus-on-abecma

Novo Nordisk Buys 2seventy's Hemophilia A ...
06/27/2024 17:17:39

2seventy Bio finalized an asset purchase agreement with Novo Nordisk involving the Hemophilia A program and in vivo gene editin...

volkswagen-puts-our-rivian-bet-in-the-black-the-pros-and-cons-of-trading-options-versus-stocks

Volkswagen Puts Our Rivian Bet In The Blac...
06/27/2024 16:39:01

Novo Nordisk, Carvana, And Now Rivian We've had bullish moves in three stocks we had bullish bets on this week, and since...

novo-nordisk-to-restrict-initial-wegovy-sales-in-china-amid-high-demand

Novo Nordisk To Restrict Initial Wegovy Sa...
06/27/2024 16:13:34

Novo Nordisk will limit initial sales of Wegovy in China to manage global supply and address the rising obesity rates in the wo...

hims--hers-health-stock-is-sliding-thursday-whats-going-on

Hims & Hers Health Stock Is Sliding Thursd...
06/27/2024 16:01:08

Hunterbrook releases a bearish report alleging that Hims & Hers sells knockoff GLP-1 weight loss drugs and relies on a sing...

Novo Will Limit Wegovy's China Launch To A...
06/27/2024 10:59:39

https://www.bloomberg.com/news/articles/2024-06-27/novo-will-limit-wegovy-s-china-launch-to-avoid-global-disruption?utm_content...

ben--jerrys-co-founders-not-worried-about-ozempics-impact-on-ice-cream-business-heres-why

Ben & Jerry's Co-Founders Not Worried Abou...
06/27/2024 05:38:40

Ben Cohen and Jerry Greenfield, the co-founders of Ben & Jerry's, are not worried about the impact of weight-loss drugs...

bernie-sanders-ozempic-will-likely-become-one-of-the-best-selling-pharmaceutical-products-in-history--americans-shouldnt-pay-10-15x-more

Bernie Sanders: 'Ozempic Will Likely Becom...
06/27/2024 01:14:31

2seventy Bio Sells Hemophilia A Candidate ...
06/26/2024 20:12:10

- Divestiture Supports Company Focus on Development and Commercialization of Abecma-

novo-nordisk-halts-late-stage-study-of-experimental-hypertension-drug-takes-over-800m-impairment-charge

Novo Nordisk Halts Late-Stage Study Of Exp...
06/26/2024 18:10:12

Novo Nordisk announced the failure of its phase 3 CLARION-CKD trial, which investigated ocedurenone for treating uncontrolled h...

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
06/26/2024 17:35:22

Novo Nordisk Stops OCEDURENONE Clarion-CKD...
06/26/2024 17:21:50

- Reuters

Reported Earlier, Novo Nordisk Stops The O...
06/26/2024 15:25:01

- Reuters

rivian-lucid-micron-technology-novo-nordisk-tesla-why-these-5-stocks-are-on-investors-radars-today

Rivian, Lucid, Micron Technology, Novo Nor...
06/26/2024 01:32:39

On Tuesday, U.S. stocks showed mixed results. The Dow Jones Industrial Average closed down by nearly 0.8%, finishing at 39,112.16

novo-nordisks-older-generation-weight-loss-drug-saxenda-associated-with-decreased-bone-mass-density-study-shows

Novo Nordisk's Older Generation Weight-Los...
06/25/2024 18:12:26

Novo Nordisk's Saxenda study published in JAMA Network Open reveals significant declines in bone density among patients, ra...

BMO Capital Maintains Outperform on Novo N...
06/25/2024 16:41:04

BMO Capital analyst Evan David Seigerman maintains Novo Nordisk (NYSE:NVO) with a Outperform and maintains $163 price target.

why-novo-nordisk-shares-are-trading-higher-tuesday

Why Novo Nordisk Shares Are Trading Higher...
06/25/2024 15:58:10

The company's weight loss drug Wegovy has been approved in China, the second most populated country that is estimated to ha...

a-closer-look-at-novo-nordisks-options-market-dynamics

A Closer Look at Novo Nordisk's Options Ma...
06/25/2024 15:31:17

CLASS ACTION DEADLINES - JOIN NOW!

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

07/16/2024 Teladoc Health, Inc. (TDOC)

07/16/2024 Vestis Corporation (VSTS)

07/22/2024 Cambium Networks Corporation (CMBM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)

NVONOVO NORDISK A S

NYSE novonordisk.com

$ 145.43 $ 2.68 (1.88 %)

Monday, 01-Jul-2024 15:59:55 EDT